Tema Etfs LLC Exelixis, Inc. Transaction History
Tema Etfs LLC
- $241 Billion
- Q4 2024
A detailed history of Tema Etfs LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 49,256 shares of EXEL stock, worth $1.68 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
49,256Holding current value
$1.68 Million% of portfolio
0.68%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
563Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.01 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$802 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$523 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$390 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...